Gimlet Labs, Inc. | $80,000,000 | (Mar 26, 2026)
Highlight(US) | $40,000,000 | (Mar 26, 2026)
BrainGrid | $1,000,000 | (Mar 26, 2026)
Perpetual Medicines
China
- Shanghai
- 01/12/2023
- Seed
- $8,000,000
About Perpetual Medicines
Perpetual Medicines is a fully integrated computational peptide therapeutics company that aims to build the next-generation peptide drug discovery engine. Perpetual Medicines’ platform will combine leading-edge methods in computational physics including MD simulation, FEP, and quantum chemistry with next-generation AI technologies to predict numerous peptide properties with supreme accuracy. We will also couple this “dry” platform with large-scale synthetic laboratory using state-of-the-art biophysical and chemistry methods for high-throughput peptide synthesis & experimentation. Our vision is to disrupt the enormous 40bn-a-year peptide drug market by heralding in a new renaissance in peptide discovery, design & development.
- Industry Biotechnology Research
- Website https://perpetualmeds.com/index
- LinkedIn https://www.linkedin.com/company/perpetual-medicines/about/
Related People
Kerry BlanchardCo Founder
China -
Jing'an District, Shanghai
Drug discovery and development, cell cycle regulation and control, biology of hypoxia, epigenetics, cancer genetics, translational science
NOPALERA | $4,000,000 | (Mar 26, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Worth AI | $30,000,000 | (Mar 26, 2026)
Hanover Park | $27,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)
Talino Fintech Foundry | $7,500,000 | (Mar 26, 2026)
Doctronic | $40,000,000 | (Mar 26, 2026)
Thesis Care | $45,000,000 | (Mar 26, 2026)
Cleavr | $1,158,600 | (Mar 24, 2026)